Annovis Bio Demonstrates Improved Axonal Transport in Nerve Cells and Brain of Down Syndrome Mice, an Animal Model of Alzheimer’s Disease
Annovis Bio Demonstrates Improved Axonal Transport in Nerve Cells and Brain of Down Syndrome Mice, an Animal Model of Alzheimer’s Disease
Manuscript Published in Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association
Study adds further validation that Annovis’ lead compound is the only drug to improve axonal transport, the information highway of the nerve cell
Comments are closed.